“…In contrast to the bioactivity-guided comparative screening, the second method for the elucidation of wound-activated chemical defence mechanisms, namely comparative metabolic screening, is based on a comparison of the metabolite pattern of extracts from intact and injured fruiting bodies. [57] Secondary metabolites which are only present in significant amounts in injured fruiting bodies are potential candidates for defence compounds, while secondary metabolites which are only present in intact fruiting bodies might be their potential precursors. In contrast to the comparative biological screening of crude extracts, the comparative metabolic screening allows often recognition of the relationship between precursor and the corresponding defence compound, especially if the metabolic screening is performed by LC-UV, LC-ESIMS or GC-EIMS, since the precursor and the www.chemeurj.org corresponding active metabolite usually share structural elements which are reflected in similar UV spectra, MS/MS spectra or fragmentation patterns in the GC-EIMS.…”